PQA 07 - PQA 07: Head and Neck Cancer, Lung Cancer/Thoracic Malignancies, and Nursing and Supportive Care

Presentations

• 03:45pm - 05:00pm ET

  4DCT Ventilation Imaging-Guided Functional Lung Avoidance Radiotherapy: A Dosimetric and NTCP-Predicted Radiation Pneumonitis Risk Assessment

  Speaker: Zhi Chen, - West China Longquan Hospital, Sichuan University; The First People’s Hospital of Longquanyi District, Chengdu
• 03:45pm - 05:00pm ET

  Association of Daily Diet and Incidence of Head and Neck Cancer: A Prospective Cohort Study of UK Biobank Participants

  Speaker: Ziyan Zhang, - West China Hospital of Sichuan University, Department of Oto-laryngology, Chengdu
• 03:45pm - 05:00pm ET

  Exploratory Study on Prophylactic Irradiation of Visible Lymph Nodes in Low-Risk Regions of Nasopharyngeal Carcinoma (VNRT): A Prospective Phase II Trial

  Speaker: Wenjun Liao, PhD - Sichuan Cancer Hospital & Institute, Cancer Hospital affiliate to School of Medicine, University of Electronic Science and Technology of China, Chengdu
• 03:45pm - 05:00pm ET

  Neoadjuvant or Adjuvant Immunotherapy in Nasopharyngeal Carcinoma: Which Strategy Optimizes Survival, Compliance, and Cost-Effectiveness?

  Speaker: Sai-Lan Liu, - Sun Yat-Sen University Cancer Center, Guang Dong Province
• 03:45pm - 05:00pm ET

  Twice Daily, Four Days a Week: Single-Institution Outcomes of Accelerated RT 60 Gy/30 for T1 Glottic Cancer with/without Weekly Docetaxel

  Speaker: Hideki Minatogawa, MD - Hokkaido Cancer Center, Sapporo
• 03:45pm - 05:00pm ET

  A Retrospective Analysis of 32 Patients with Primary Nasopharyngeal Mucoepidermoid Carcinoma

  Speaker: Shan Shan Guo, - Sun Yat-Sen University Cancer Center, Guang Dong Province
• 03:45pm - 05:00pm ET

  Immunonutrition for Prevention of Radiotherapy-Induced Severe Oral Mucositis in Head and Neck Cancer: Clinical and Cost-Effectiveness Analysis

  Speaker: Qiao Qiao, MD, BS, BSN - The First Hospital of China Medical University,
• 03:45pm - 05:00pm ET

  Adjuvant Radiotherapy is Associated with Improved Risk-Adjusted Outcomes in Resected Salivary Gland Cancers

  Speaker: Jeffrey Shogan, DO - University of Pittsburgh Medical Center, Pittsburgh
• 03:45pm - 05:00pm ET

  Safety and Within-Session Tongue Position Stability with a Patient-Specific Negative-Pressure Intraoral Spacer Assessed on Fluoroscopy and MRI: Proof-of-Concept Studies in Healthy Volunteers and Tongue Cancer Patients

  Speaker: Takuya Nagano, - Tokyo Medical and Dental University, Tokyo
• 03:45pm - 05:00pm ET

  Efficacy of PD-1 Inhibitors Combined with Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma with High-Grade Radiological Extranodal Extension

  Speaker: Yan Zou, BS - Guizhou Cancer Hospital, Guiyang
• 03:45pm - 05:00pm ET

  A Two-Stage Latent Diffusion Model for Predicting FBCT Images During Radiotherapy: Enabling Adaptive Radiotherapy Trigger Monitoring with Reduced Scanning Frequency

  Speaker: Guan-Qun Zhou, MD, PhD - Sun Yat-Sen University Cancer Center, Guang Dong Province
• 03:45pm - 05:00pm ET

  Research on the Development and Application of Bundled Care Protocols for Radiation Dermatitis in Nasopharyngeal Cancer Patients

  Speaker: Jia Cao, - Department of Head and Neck Oncology, Affiliated Tumor Hospital of Guizhou Medical University, Guiyang
• 03:45pm - 05:00pm ET

  Dosimetric Benefit of Personalised PTV Margin Reduction for Head and Neck Radiotherapy

  Speaker: Claire Fitzpatrick, BS - St.Luke's Radiation Oncology Network, Dublin
• 03:45pm - 05:00pm ET

  Predictors of Patient-Reported Dysphagia after Transoral Robotic Surgery and De-Intensified Adjuvant Radiation Therapy for HPV-Associated Oropharyngeal Squamous Cell Carcinoma

  Speaker: Matthew Riina, MD - Hospital of the University of Pennsylvania, Philadelphia
• 03:45pm - 05:00pm ET

  A Causal Digital Twin Framework for Personalized Chemoradiotherapy Intensification in Head and Neck Cancer

  Speaker: Keyur Shah, PhD - Emory University, Atlanta
• 03:45pm - 05:00pm ET

  Proton Beam Therapy vs. Intensity-Modulated Radiation Therapy in Oropharyngeal Cancer: A Systematic Review and Individual Patient Data Meta-Analysis

  Speaker: Chia Ching Lee, MD - National University Cancer Institute Singapore, Singapore
• 03:45pm - 05:00pm ET

  Tislelizumab Combined with Nimotuzumab and Chemotherapy without Concurrent Cisplatin for Local Advanced Nasopharyngeal Carcinoma

  Speaker: Jianping Wang, - First Affiliated Hospital of Soochow University, Soochow
• 03:45pm - 05:00pm ET

  Proton Beam Therapy in the Treatment of Salivary Gland Malignancies of the Head and Neck: A Single Institution Review

  Speaker: Lisa McGee, MD - Mayo Clinic, Phoenix
• 03:45pm - 05:00pm ET

  Prospective Phase II Single-Arm Multicenter Study of Nimotuzumab plus Benmelstobart and Platinum-Based Doublet Neoadjuvant Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

  Speaker: Yuanyuan Chen, MD - Sun Yat-Sen University Cancer Center, Guang Dong Province
• 03:45pm - 05:00pm ET

  LLM-Based Structured Clinical Information Integration Enhances Multimodal Target Delineation and Dose-Prescription Guidance in Nasopharyngeal Carcinoma

  Speaker: Xianyue Zeng, - Department of Radiation Oncology, Sun yat-sen University Cancer Center, Guangzhou
• 03:45pm - 05:00pm ET

  Outcomes of Surgery, Concurrent Chemoradiotherapy, and Definitive Radiotherapy in Early-Stage Oral Cancer: A National Database Analysis

  Speaker: Chia-Jen Tsai, MD - Chi-Mei Medical Center, Tainan City
• 03:45pm - 05:00pm ET

  Dosimetric Evaluation of Arterial Branches Used In Flap Reconstruction In Locally-Advanced Laryngeal Cancer

  Speaker: Krishna Hanubal, MD - UC Irvine Health, Orange
• 03:45pm - 05:00pm ET

  ICRU 83-Informed Dose Layering to Reduce Temporal Lobe Injury Risk in T4 Nasopharyngeal Carcinoma: A Prospective Cohort Study with a Contemporaneous Comparator

  Speaker: Yongzheng Lai, - Jiangxi Medical College, Nanchang University, Nanchang
• 03:45pm - 05:00pm ET

  AKT, ATR and Notch Inhibitors Radiosensitize a Preclinical Model of Adenoid Cystic Carcinoma

  Speaker: Shyam Nyati, PhD - University of Michigan, Ann Arbor
• 03:45pm - 05:00pm ET

  Beyond Traditional Models: Machine Learning Identification of Interaction Effects In ORN

  Speaker: Ali Sabbagh, MD - Memorial Sloan Kettering Cancer Center, New York
• 03:45pm - 05:00pm ET

  Is Time of the Essence? Site-Specific Impact of Induction Chemotherapy-to-Radiation Interval Length on Outcomes for Locally Advanced Head and Neck Cancer (LA-HNC)

  Speaker: Evelyn Chang, - Johns Hopkins School of Medicine, Baltimore
• 03:45pm - 05:00pm ET

  Circulating Epstein-Barr Virus DNA Level Post Induction Chemotherapy Contributes to Prognostication in Nonmetastatic Nasopharyngeal Carcinoma Treated with Intensity Modulated Radiotherapy (IMRT) + Carbon-Ion Beam Radiotherapy (CIRT)

  Speaker: Yujiao Li, MD - Fudan University Shanghai Cancer Center, ShangHai
• 03:45pm - 05:00pm ET

  Dynamic Changes In Apparent Diffusion Coefficient Predict Radiation-Induced Sternocleidomastoid Muscle Atrophy In Nasopharyngeal Carcinoma

  Speaker: Ming Fan, MD, PhD - Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affili, Cheng Du
• 03:45pm - 05:00pm ET

  Reproducibility of Clinician-Reported Acute Symptom Burden during Head and Neck Chemoradiation: A Prospective Blinded Analysis from a Randomized Trial

  Speaker: Shwetabh Sinha, MD, MBBS - ACTREC, TMC, Navi Mumbai
• 03:45pm - 05:00pm ET

  Toward Fully Automated VMAT Planning for Oropharyngeal Cancer: A Clinical Validation Study

  Speaker: William Green, MD - Rutgers Cancer Institute of New Jersey, New Brunswick
• 03:45pm - 05:00pm ET

  Association of Oncogenic CASP8 Mutations With Bone Invasion in Oral Cavity Carcinoma

  Speaker: Sean Choi, BS - Case Western Reserve University School of Medicine, Cleveland
• 03:45pm - 05:00pm ET

  Impact of Adjuvant Radiation and Immunotherapy on Survival in Head and Neck Mucosal Melanoma

  Speaker: Ashlynn Gober, MD - University of Utah, Salt Lake City
• 03:45pm - 05:00pm ET

  Real-Time Circulating Tumor HPV DNA Kinetics to Guide Adaptive Radiotherapy De-Escalation in HPV-Associated Oropharyngeal Cancer: Interim Results of a Phase II Trial

  Speaker: Sujith Baliga, MD - The Ohio State University , Dublin
• 03:45pm - 05:00pm ET

  Does a Custom 3D Printed Radiotherapy Oral Positioning Device Improve Tongue Positioning Reproducibility? Lessons Learned from a Retrospective Study

  Speaker: Gregory Boutis, - Mayo Clinic, Scottsdale
• 03:45pm - 05:00pm ET

  The Burden of Cardiovascular Disease in Long-Term Survivors of Nasopharyngeal Cancer: A Population-Based Cohort Study

  Speaker: Ruyu Xu, MS, MBBS - University of Hong Kong, Hong Kong
• 03:45pm - 05:00pm ET

  A Randomized Study of Head and Neck Radiotherapy with or without Customized 3D Printed Oral Stents

  Speaker: Anna Lee, MD, MPH - University of Texas MD Anderson Cancer Center, Houston
• 03:45pm - 05:00pm ET

  Patterns of Failure and Disease Recurrence in Nasopharyngeal Cancer: A Five-Year Analysis in an EBV Endemic Population at Pakistan's Largest Cancer Center

  Speaker: Adeel Riaz, MD, M.Phil. - Rutgers Health/Robert Wood Johnson Medical School, New Brunswick
• 03:45pm - 05:00pm ET

  Timing and Utility of Repeat Post-Treatment PET/CT in Head and Neck Squamous Cell Carcinoma

  Speaker: Anurag Singh, MD, FASTRO - Roswell Park Cancer Institute, Buffalo
• 03:45pm - 05:00pm ET

  Propensity Score-Matched Comparison of Dosimetry and Outcomes of Mucosal-Sparing IMPT and IMRT In South Asian Oral and Oropharyngeal Cancer Patients

  Speaker: Sapna Nangia, MD, MBBS - Indraprastha Apollo Hospital, New Delhi
• 03:45pm - 05:00pm ET

  Superficial Hypofractionated Radiation Therapy for Nonmelanoma Skin Cancer (NMSC): Comparable Outcomes across Fractionation Schedules

  Speaker: Jessica Ortega, MD - UC Health, Cincinnati
• 03:45pm - 05:00pm ET

  Combined Proton/Photon Therapy in Skull-Base Approximating Head and Neck Cancers

  Speaker: James Knight, MD - Johns Hopkins Proton Therapy Center, Washington
• 03:45pm - 05:00pm ET

  Audiologic Surveillance Gaps and Hearing Threshold Shifts Following IMRT for Head and Neck Cancer

  Speaker: Connie Chang-Chien, BS - University of California, San Francisco, San Francisco
• 03:45pm - 05:00pm ET

  Cesium-131 Brachytherapy vs. SBRT for Frail Patients with Head and Neck Cancers Not Eligible for Conventional External Beam Radiation Therapy

  Speaker: Kirti Sharma, BS - Virginia Commonwealth University School of Medicine, Richmond
• 03:45pm - 05:00pm ET

  NPC-SurvNet: A Dosimetry-Aware Longitudinal Multi-Modal Transformer for Precision Prognostication in Nasopharyngeal Carcinoma

  Speaker: Jiping Liu, RT - Zhejiang Cancer Hospital, Hangzhou
• 03:45pm - 05:00pm ET

  Radiotherapy for Early T-Stage Nasopharyngeal Carcinoma: A Prospective Observational Study on the Safety of Petrous Apex-Sparing Irradiation and Dosimetry Benefits of Cochlear

  Speaker: Deqing Liu, - Department of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Cancer Hospital, Chongqing
• 03:45pm - 05:00pm ET

  Long-Term Follow-up Analysis of Locoregionally Advanced Nasopharyngeal Carcinoma in Non-Endemic Regions of China: A Multicenter Retrospective Study Based on the 9th Edition AJCC/UICC Staging System

  Speaker: Tong Bu, - Nanjing Medical University, Nanjing
• 03:45pm - 05:00pm ET

  Phase II Trial of QL1706 in Combination with Liposomal Irinotecan for Recurrent or Metastatic Nasopharyngeal Carcinoma Progressing after Anti-PD-(L)1 Therapy

  Speaker: Yesheng Du, - Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing
• 03:45pm - 05:00pm ET

  Phase II Trial of Tislelizumab plus Chemotherapy with Response-Adapted Radiotherapy for De Novo Metastatic Nasopharyngeal Carcinoma

  Speaker: Chengchen Wang, MD - Department of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Cancer Hospital, Chongqing
• 03:45pm - 05:00pm ET

  Development and External Validation of an Autonomous Multimodal Artificial Intelligence Agent for Adaptive Radiotherapy Decision-Making In Nasopharyngeal Carcinoma

  Speaker: Suman Zhang, MD - Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Key Laborat, Guangzhou
• 03:45pm - 05:00pm ET

  Radiation De-Escalation for Human Papillomavirus Negative Oropharyngeal Cancer and Laryngeal/Hypopharyngeal Cancers: Primary Outcomes of a Pilot Study

  Speaker: Zeinab Abou Yehia, MD - Rutgers Cancer Institute of New Jersey, New Brunswick
• 03:45pm - 05:00pm ET

  Exploratory Analysis of Lymph Node Ratio and Iodine-Avid Disease Extent After Radioactive Iodine Treatment in Differentiated Thyroid Cancer

  Speaker: Samantha Cortes-Iriarte, - Herbert Wertheim College of Medicine, Florida International University, Miami
• 03:45pm - 05:00pm ET

  UMCC 2023.006: A Pilot Phase II Trial of Individualized FDG-PET and DCE-MRI Directed Adaptive RT in HPV-related Stage III Oropharynx Cancer

  Speaker: Luke Higgins, MD - University of Michigan, Ann Arbor
• 03:45pm - 05:00pm ET

  Automated Volumetric Muscle Assessment Refines Identification of High-Risk Sarcopenia in Head and Neck Radiotherapy

  Speaker: Sang Min Lee, - Seoul National University College of Medicine, Seoul
• 03:45pm - 05:00pm ET

  Perioperative Pembrolizumab and Intraoperative Radiation with or without Preoperative Radiotherapy in Recurrent/Persistent Head and Neck Squamous Cell Carcinoma: Interim Analysis of a Randomized Pilot Trial

  Speaker: Sujith Baliga, MD - The Ohio State University , Dublin
• 03:45pm - 05:00pm ET

  Radiation Dose Predicts Wound Complications in Patients Undergoing Mandibular Reconstruction

  Speaker: Matthew Spector, MD - University of Pittsburgh, Pittsburgh
• 03:45pm - 05:00pm ET

  Comparative Analysis of Induction Chemotherapy vs. Upfront Surgery for Locally Advanced Oral Tongue Cancer

  Speaker: Adeel Riaz, MD, M.Phil. - Rutgers Health/Robert Wood Johnson Medical School, New Brunswick
• 03:45pm - 05:00pm ET

  Improved Outcomes with Adjuvant Radiotherapy for Resected Squamous Cell Carcinomas of the Retromolar Trigone, Alveolar Ridge & Buccal Mucosa

  Speaker: Alberto Vera, MD - UPMC Cancer Center, Pittsburgh
• 03:45pm - 05:00pm ET

  FLASH Proton Radiotherapy Preserves Ocular Structure and Function without Compromising Antitumor Efficacy

  Speaker: Uri Amit, MD, PhD, MPH - Tel Aviv Medical Center, Tel Aviv
• 03:45pm - 05:00pm ET

  Patterns of Failure and Salvage Treatment Outcomes in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Chemoradiation

  Speaker: Poonam Dalwadi, MD, BS - Washington University/B-JH/SLCH Consortium, St. Louis
• 03:45pm - 05:00pm ET

  Long Term Outcomes of Delays in Adjuvant Treatments Among Patients with Head and Neck Cancer

  Speaker: Mahwish Mallick, - The Ohio State University College of Medicine, Columbus
• 03:45pm - 05:00pm ET

  Voxel-Level ¹⁸F-FDG PET/MRI Derived Dose-Response and Tumor Control Probability Modeling to Identify Primary and Acquired Resistance for Locally Advanced Nasopharyngeal Carcinoma

  Speaker: Shu Zhang, MD - West China Hospital, Sichuan University, Chengdu
• 03:45pm - 05:00pm ET

  Rethinking Parotid Lymph Node Assessment in NPC: Why 10 mm is Not Enough and How Node-RADS Refines the Biopsy Threshold

  Speaker: Jingyu Zhu, MBBS - Fujian Medical University, Fuzhou
• 03:45pm - 05:00pm ET

  Interim Analysis of a Prospective Trial of Upright Image-Guided Proton Therapy for Recurrent Lung, Brain, and Head and Neck Malignancies

  Speaker: Philip Blumenfeld, MD, MPH - Hadassah Medical Center, Jerusalem
• 03:45pm - 05:00pm ET

  Recurrence Patterns Relative to Residual Tumor after Induction Chemotherapy in Nasopharyngeal Carcinoma

  Speaker: Peng Ding, - JiangXi Medical College,Nanchang University, Nanchang
• 03:45pm - 05:00pm ET

  Radiation-Induced Brain Necrosis Following Proton Therapy for Head and Neck Cancers near the Skull Base: Incidence and Predictive Factors

  Speaker: Hao-Shen Cheng, MD - Memorial Sloan Kettering Cancer Center, New York
• 03:45pm - 05:00pm ET

  Twelve-Month Swallowing Outcomes in a Phase II Trial of PET-Adapted Radiation for HPV-Associated Oropharynx Squamous Cell Carcinoma

  Speaker: Luke Higgins, MD - University of Michigan, Ann Arbor
• 03:45pm - 05:00pm ET

  A Delphi Consensus Recommendations for the Management of Radiation-Induced Hearing Loss in Patients with Nasopharyngeal Carcinoma

  Speaker: Ying Wang, PhD - Department of Radiation Oncology, Chongqing Cancer Hospital & Cancer Institute, Chongqing
• 03:45pm - 05:00pm ET

  Real-World Evidence on the Impact of Adjuvant Radiation Timing for HPV Related Oropharyngeal Cancer in a Nationwide Cohort

  Speaker: Sreenija Yarlagadda, MD - Miami Cancer Institute, Miami
• 03:45pm - 05:00pm ET

  Long-Term Outcomes After Stereotactic Radiation Therapy for Head and Neck Cancers with Perineural Spread

  Speaker: Christopher Goodman, MD - University of Western Ontario, London
• 03:45pm - 05:00pm ET

  Tumor Regression after 4 Weeks of Definitive Radiotherapy Predicts Outcomes in Oropharyngeal Cancer

  Speaker: Isaac Lasko, MD - Loyola University Medical Center, Maywood
• 03:45pm - 05:00pm ET

  Early-Stage Laryngeal Cancer Treatment Outcomes with Whole vs. Partial Laryngeal Radiotherapy

  Speaker: Andrew Wanna, MD - New York University Cancer Center, New York
• 03:45pm - 05:00pm ET

  Incidence Trends and Clinical Outcomes in Young Patients with Oral Cavity Cancer: A Multi-Decade Analysis from a Tertiary Care Center

  Speaker: Alexander Qian, MD - University of California San Francisco, San Francisco
• 03:45pm - 05:00pm ET

  Clinical Predictors of Reactive Gastrostomy Tube Placement During Radiation Therapy for Locally Advanced Head and Neck Cancer

  Speaker: Paul Buclez, MS, BS - California Northstate University College of Medicine, Elk Grove
• 03:45pm - 05:00pm ET

  Association of Body Mass Index with Long Term Outcomes Among Patients with Head and Neck Cancer Who Received Upfront Surgery with or without Adjuvant Treatments

  Speaker: Daniel Alvarez, - The Ohio State University, Columbus
• 03:45pm - 05:00pm ET

  The Compounding Effects of Socioeconomic and Access Barriers on Guideline-Concordant Care for Oropharyngeal Squamous Cell Carcinoma

  Speaker: Sudarshan Ramanan, - Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia
• 03:45pm - 05:00pm ET

  Voice Outcome Following Salvage Moderately Hypofractionated Radiotherapy after Transoral Microsurgery for Early-Stage Glottic Squamous Cell Carcinoma

  Speaker: Byung Han Rhieu, MD - Johns Hopkins Hospital, Radiation Oncology, baltimore
• 03:45pm - 05:00pm ET

  Stereotactic Radiation for Recurrent and Metastatic Thyroid Cancer: Site-Dependent Local Control in the Modern Systemic Therapy Era

  Speaker: Bin Gui, MD, MS - Northwell Health, Lake Success
• 03:45pm - 05:00pm ET

  Impact of Age and Frailty on Outcomes among Patients Undergoing Curative-Intent Treatment for Head and Neck Squamous Cell Carcinomas (HNSCC)

  Speaker: Emily Vonderhaar Meister, MD, PhD - Johns Hopkins Hospital, Baltimore
• 03:45pm - 05:00pm ET

  Validation and Refinement of the AJCC/UICC TNM-9 M1 Category in Metachronous Metastatic Nasopharyngeal Carcinoma: A Recursive Partitioning Analysis for Improved Risk Stratification

  Speaker: Daqiang Huang, MD - Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China., Fuzhou
• 03:45pm - 05:00pm ET

  Association Between Radiotherapy Dose to Contralateral Substructures and Post-Treatment Dysphagia in Oropharyngeal Cancer

  Speaker: Mahrukh Naqvi, - University of Cincinnati College of Medicine, Cincinnati
• 03:45pm - 05:00pm ET

  Evaluating Adaptive SBRT for Head and Neck Malignancies: Practice Patterns, Toxicity, and Outcomes

  Speaker: Jared Hobson, MD, BSN, RN - Mayo Clinic Rochester, Rochester
• 03:45pm - 05:00pm ET

  Funnel-Shaped PTV Margins for Optimized Target Coverage and OAR Sparing in Nasopharyngeal Carcinoma Radiotherapy

  Speaker: Lihua Ning, - Department of Radiation Oncology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
• 03:45pm - 05:00pm ET

  Prospective Study of Radiation Dose to Dysphagia-Aspiration Related Structures and Patient-Reported Swallowing Outcomes in Head and Neck Squamous Cell Carcinoma

  Speaker: Kanika Sharma, MBBS - Dharamshila Narayana Super Speciality Hospital, Delhi
• 03:45pm - 05:00pm ET

  Risk Stratification of Advanced Extranodal Extension in Retropharyngeal Lymph Nodes for Nasopharyngeal Carcinoma: A Multi-Center Study

  Speaker: Junyi Liu, MB - Department of Radiation Oncology, Jiangsu Cancer Hospital/Jiangsu Institute of Cancer Research/The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing
• 03:45pm - 05:00pm ET

  PET-CECT-bAsed RadIotherapy PlaNning WiTh SUV-Directed Dose Escalation in InopeRable (PAINTER) Head and Neck Cancer Patients: Prospective Single Institutional Experience

  Speaker: Umesh Velu, - Kasturba Medical College, Manipal
• 03:45pm - 05:00pm ET

  Intratumoral Microbiome Landscape, Clinical Stage, and Survival in Hypopharyngeal Cancer

  Speaker: Dan Zuo, - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing
• 03:45pm - 05:00pm ET

  Structure-Specific Involvement in Advanced Cervical Lymph Node Extranodal Extension Predicts Prognosis in Nasopharyngeal Carcinoma: A Multi-Center Study

  Speaker: Junyi Liu, MB - Department of Radiation Oncology, Jiangsu Cancer Hospital/Jiangsu Institute of Cancer Research/The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing
• 03:45pm - 05:00pm ET

  Genomic Analysis of Clinical Outcomes in p16-Postive Oropharyngeal Cancer and Identification of Low Frequency High-Risk Mutations

  Speaker: Matthew Brown, MD - University of Maryland Radiation Oncology, Baltimore
• 03:45pm - 05:00pm ET

  Generalizability of an Automatic GTV Segmentation Model in the Reirradiation Setting for Oropharyngeal Cancer

  Speaker: Arnaud Beddok, MD, PhD - Institute Jean Godinot, Reims 51056
• 03:45pm - 05:00pm ET

  Intraoperative Cs-131 Brachytherapy after Salvage Resection for Recurrent/High-Risk Head & Neck Cancer in Frail Patients: A Contemporary Comparison with RTOG 9610

  Speaker: Bin Gui, MD, MS - Northwell Health, Lake Success
• 03:45pm - 05:00pm ET

  Personalized Prediction of Radiation-Induced Oral Toxicity Using a Nomogram in Nasopharyngeal Carcinoma

  Speaker: Rui Guo, MD - Sun Yat-sen University Cancer Center, Guangzhou
• 03:45pm - 05:00pm ET

  Vocal Cord-Only Radiotherapy Minimizes Tracheostomy Risk in Early Glottic Cancer

  Speaker: Issa Mohamad, MD - King Hussein Cancer Center, Amman
• 03:45pm - 05:00pm ET

  Modern Adjuvant Radiotherapy for Carcinoma Ex Pleomorphic Adenoma of the Lacrimal and Salivary Glands: A Multi-Institutional Study

  Speaker: Rodney Cheng-En Hsieh, MD, PhD - Chang Gung Memorial Hospital Linkou Branch, Taoyuan City
• 03:45pm - 05:00pm ET

  Validation and Development of N Category for Nasopharyngeal Carcinoma Based on the Ninth Version of AJCC/UICC TNM Staging System in Non-High-Incidence Regions of China: A Multicenter Cohort Study

  Speaker: Tong Jin, - Nanjing Medical University Affiliated Cancer Hospital, Nanjing
• 03:45pm - 05:00pm ET

  Baseline Oral Microbial Alpha Diversity Is Associated with Systemic Inflammatory Response during Radiotherapy for Head and Neck Cancer

  Speaker: Atsushi Ue, MD, PhD - Shimane University Hospital, izumo
• 03:45pm - 05:00pm ET

  Outcomes of Neoadjuvant Chemo-immunotherapy Followed by Radical Surgery vs. Definitive Chemoradiotherapy in Patients with T4b Head and Neck Squamous Cell Carcinoma

  Speaker: Anqi He, - sun yet university cancer center, guangzhou
• 03:45pm - 05:00pm ET

  Prognostic Value of Necrotic Features in Cervical Lymph Nodes in Stage IB Nasopharyngeal Carcinoma: Base on the 9th Edition AJCC/UICC Staging System

  Speaker: Jing Zhong, MD, PhD - Fujian Cancer Hospital, Fuzhou
• 03:45pm - 05:00pm ET

  Prognostic Significance of Pathologic Complete Response after Neoadjuvant TPF Chemotherapy in Stage IV Oral Cavity Squamous Cell Carcinoma

  Speaker: Chihsien Huang, MD - China Medical University Hospital, Taichung
• 03:45pm - 05:00pm ET

  Risk-Adapted Strategy for N3 Nasopharyngeal Carcinoma: Impact of Induction Chemotherapy Response and the Role of Upfront Neck Dissection for Poor Responders

  Speaker: Yi Chun Liu, MD - Taichung Veterans General Hospital, Taichung
• 03:45pm - 05:00pm ET

  Whole-Body FDG PET Identifies Occult Gross Residual Disease prior to Adjuvant Chemoradiotherapy in High-Risk HNSCC: Prospective Findings from the Phase II HYPCON-02 Trial

  Speaker: Aman Sharma, MD, DO, DSc - All India Institute of Medical Sciences, Healthcare, Practitioner and Technician
• 03:45pm - 05:00pm ET

  Artificial Intelligence-Augmented Cardiac Transit Modeling Pilot Improves Risk Stratification for Radiation-Induced Lymphopenia: A Novel Translational Dosimetric Approach

  Speaker: Enes Atici, MD - University of Kentucky, Lexington
• 03:45pm - 05:00pm ET

  Treatment Paradigms and Patterns of Failure in Locally Advanced Sinonasal Malignancies: A Single-Institution Experience

  Speaker: Ashlynn Gober, MD - University of Utah, Salt Lake City
• 03:45pm - 05:00pm ET

  Ctdna-Based Adjuvant De-Escalation of Chemoradiation In High-Risk HPV-Associated Squamous Cell Carcinomas of the Oropharynx: Early Results of a Single Institution Phase 2 Trial

  Speaker: Achraf Shamseddine, MD, PhD - Memorial Sloan Kettering Cancer Center, New York
• 03:45pm - 05:00pm ET

  Comparative Analysis of Intratumoral Microbiomes in HPV-Associated Oropharyngeal and Cervical Cancers

  Speaker: Yingjie Zhu, MD - Memorial Sloan Kettering Cancer Center, New York
• 03:45pm - 05:00pm ET

  Patterns of Recurrence in HPV-Associated Oropharyngeal Squamous Cell Carcinoma after Surgery Alone vs. Surgery plus De-Escalated Adjuvant Radiotherapy

  Speaker: Andres Frias, MD - Mayo Clinic College of Medicine and Science Rochester, Rochester
• 03:45pm - 05:00pm ET

  A Prospective Comparison of Dysphagia-Optimised and Standard: IMRT in Oral Cavity Cancer

  Speaker: Himanshu Mishra, - Institute of Medical Sciences, Banaras Hindu University, Varanasi, India, Varanasi
• 03:45pm - 05:00pm ET

  Hypoxia Region Dose Escalation in Head and Neck Cancer - Early Clinical Results of Multicenter Study

  Speaker: Martin Dolezel, MD, PhD - University Hospital Olomouc, Olomouc
• 03:45pm - 05:00pm ET

  Survival and Toxicity Outcomes of Twice-Daily (BID) Accelerated Hyperfractionated Reirradiation in Head and Neck Cancers (HNC)

  Speaker: Victoria Doss, MD - Johns Hopkins Medicine, Baltimore
• 03:45pm - 05:00pm ET

  Local Control and Dose-Response of Radiation Therapy for Bone Metastases in Differentiated Thyroid Cancer

  Speaker: Qian Liu, MD - Mayo Clinic Rochester, Rochester
• 03:45pm - 05:00pm ET

  Timing of Pre- vs. Post-Radiation Weekly Cisplatin Infusion for SCC of the Head and Neck or Cervix Uteri and Impact on Outcomes

  Speaker: Carla Fitch, MD - Mass General Brigham/Massachusetts General Hospital/Harvard Med School, Boston
• 03:45pm - 05:00pm ET

  Association of Immune Status with Treatment Efficacy in Patients with Cutaneous Squamous Cell Carcinoma Treated with Immune Checkpoint Inhibition

  Speaker: Ashonti Wright, BA - Cleveland Clinic Foundation, Cleveland
• 03:45pm - 05:00pm ET

  External Beam Radiotherapy is Effective and Well Tolerated in Unresectable Primary or Recurrent Differentiated Thyroid Cancer

  Speaker: Jana Kobeissi, MD - Cleveland Clinic Foundation, Cleveland
• 03:45pm - 05:00pm ET

  Beyond Overlap Metrics: Uncertainty-Based Triage for Pathology-Anchored QA of Nodal Autosegmentation In HPV-Positive Oropharyngeal Cancer

  Speaker: Yehia Mohamed, MD - Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston
• 03:45pm - 05:00pm ET

  Biopsy-Resection Immune Concordance Is Compartment-Dependent In Head and Neck Cancer

  Speaker: Oluwaseyi Oderinde, PhD - Purdue University, West Lafayette
• 03:45pm - 05:00pm ET

  Evaluation of Dosimetric Parameters in Patients with Head and Neck Cancer Undergoing Hypofractionated Adjuvant Radiotherapy: An Ancillary Study of HART-HN

  Speaker: Lou-Anne Acevedo-Moreno, MD - Medical College of Wisconsin, Milwaukee
• 03:45pm - 05:00pm ET

  p16 and HPV Testing Discordance and Outcomes in a Large U.S. Cohort of Patients with Oropharyngeal Squamous Cell Carcinoma

  Speaker: Jacob Jordan, MD, MS - Mayo Clinic Alix School of Medicine, Rochester
• 03:45pm - 05:00pm ET

  BED =100 Predicts Favorable Survival in HPV+ Thoracic Metastases

  Speaker: Mohammad Nehmeh, - Memorial Sloan Kettering Cancer Center, Middletown Township
• 03:45pm - 05:00pm ET

  AI-Derived CT Body Composition Phenotypes Independently Reclassify Feeding Tube Risk Beyond BMI in Head and Neck Radiotherapy

  Speaker: Charmin (Chulmin) Bang, MD - UCLA Health, Los Angeles
• 03:45pm - 05:00pm ET

  Is Elective Nodal Radiation Necessary for Advanced Differentiated Thyroid Cancer?

  Speaker: Elizabeth Obi, MD - Cleveland Clinic Foundation, Cleveland
• 03:45pm - 05:00pm ET

  Post-Operative External Beam Radiation is Effective and Well-Tolerated in Advanced Differentiated Thyroid Cancer

  Speaker: Katie Scharf, MD - Rush University Medical Center, Chicago
• 03:45pm - 05:00pm ET

  De-Intensified vs. Standard-Dose Proton Beam Therapy for Favorable Prognosis HPV-Mediated Oropharynx Cancer

  Speaker: Roi Dagan, MD, MS - University of Florida Proton Therapy Institute, Jacksonville
• 03:45pm - 05:00pm ET

  Outcomes Following Implementation of 50 Gy Postoperative Radiation for Intermediate-Risk HPV-Associated Oropharyngeal Cancer

  Speaker: Lauren Williams, MD - Memorial Sloan Kettering Cancer Center, Middletown Township
• 03:45pm - 05:00pm ET

  Induction Systemic Therapy followed by Definitive Chemoradiation for T4 Larynx and Hypopharynx Cancer

  Speaker: Nader Mohamed, MD - NYU Langone Health, New York
• 03:45pm - 05:00pm ET

  AI-Enabled Multimodal Image-Guided Radiotherapy for Nasopharyngeal Carcinoma: An Integrated Diagnostic-Therapeutic Workflow

  Speaker: Rui Guo, MD - Sun Yat-sen University Cancer Center, Guangzhou
• 03:45pm - 05:00pm ET

  Development of a Lymph Node Staging System for Nasopharyngeal Carcinoma Based on PET/CT and MRI

  Speaker: Linglong Tang, MD, PhD - Sun Yat-Sen University Cancer Center, Guangzhou
• 03:45pm - 05:00pm ET

  Survival Outcomes and Recurrence Patterns of Nasopharyngeal Carcinoma Patients Achieving Complete Response after Induction Chemotherapy: A Retrospective Cohort Study

  Speaker: Ni Zeng, - West China Hospital, Sichuan University, Chengdu
• 03:45pm - 05:00pm ET

  Comparative Outcomes and Toxicity of Surgical and Nonsurgical Salvage Approaches for Locoregionally Recurrent Head and Neck Cancer

  Speaker: Oluwatimileyin Ojo, MD - Northwell Health, Lake Success
• 03:45pm - 05:00pm ET

  Rates of Osteoradionecrosis in Sinonasal Malignancies with Current Radiation Modalities: A Systematic Review and Meta-Analysis

  Speaker: Sarah Rosmarin, MS - University of Pittsburgh Medical Center, Pittsburgh
• 03:45pm - 05:00pm ET

  Comparative Toxicity and Outcomes of IMRT vs. SBRT for Re-Irradiation in Head and Neck Squamous Cell Carcinoma

  Speaker: Lillian Zhang, BA - USF Health Morsani College of Medicine, Tampa
• 03:45pm - 05:00pm ET

  Impact of Younger Age on Clinicopathologic Presentation and Oncologic Outcomes in Oral Tongue Squamous Cell Carcinoma

  Speaker: Briana Lopez, MS, MPH - Charles R. Drew University of Medicine and Science,
• 03:45pm - 05:00pm ET

  Learning From Failure: A Multifactorial Analysis Of Locoregionally Advanced Laryngeal Cancer(Lalc) Recurrence And The Impact Of A Standardized Sop In A Resource-Limited Setting

  Speaker: Bhaskar Chakraborty, - Ahsania Mission Cancer and General Hospital, Dhaka
• 03:45pm - 05:00pm ET

  Beyond Daily IGRT: Offline Adaptive Tomotherapy with Daily MVCT In 233 Patients with Head and Neck Cancer: A Prospective Registry of Adaptation Rates, Failure Patterns, and Survival

  Speaker: Sarath K V, MD, MBBS - Amrita Institute of Medical Sciences and Research Centre, Faridabad
• 03:45pm - 05:00pm ET

  Clinical Study of Chemotherapy Plus Immunotherapy Combined with Local Liver Radiotherapy for Patients with Distant Metastatic Nasopharyngeal Carcinoma

  Speaker: Yanping Yang, - Department of Head and Neck Oncology, Affiliated Tumor Hospital of Guizhou Medical University, Guiyang
• 03:45pm - 05:00pm ET

  Comparative Evaluation of Immune, Hypoxia, and DNA Repair Transcriptomic Signatures for Predicting Radiation Therapy Response in Head and Neck Squamous Cell Carcinoma

  Speaker: Jeril Lasington, MD - NYMC-Saint Clare's Health and Saint Mary's general hospital, Denville
• 03:45pm - 05:00pm ET

  Real-World Landscape of c-MET Expression in HPV Negative Head and Neck Squamous Cell Carcinoma (HNSCC)

  Speaker: Tripti Gaur, - AVEO Pharmaceuticals, Inc., Boston
• 03:45pm - 05:00pm ET

  Is What You See What You Get? Predicting Pathologic Nodal Status from Preoperative Imaging in Human Papillomavirus-Related Oropharyngeal Cancer

  Speaker: Luke del Balzo, MD - Emory University Hospital, Atlanta
• 03:45pm - 05:00pm ET

  Serial MRI-Informed Proliferation-Saturation Index Modeling for Risk-Adapted Radiotherapy in HPV-Positive Oropharyngeal Cancer

  Speaker: Warren Floyd, MD, PhD, BS - MD Anderson Cancer Center, Houston
• 03:45pm - 05:00pm ET

  Independent Association of Baseline Pain with Reactive Feeding Tube Placement during Radiation Therapy for Head and Neck Squamous Cell Carcinoma

  Speaker: Reeny Thomas, MD, MS - University of Pittsburgh Medical Center, Pittsburgh
• 03:45pm - 05:00pm ET

  Interim Analysis of the Definitive Chemoradiation Arm (Group 4) of the DART 2 Study- Dose Adjusted Radiation Therapy Based on Midtreatment ctHPVDNA Clearance

  Speaker: David Routman, MD - Mayo Clinic Rochester, Rochester
• 03:45pm - 05:00pm ET

  Long-Term Efficacy and Toxicity of Pencil-Beam Scanning Proton and Carbon Ion Radiotherapy for Head and Neck Adenoid Cystic Carcinoma: A Decade of Experience

  Speaker: Xiyin Guan, MD - Shanghai Proton and Heavy Ion Center, Shanghai
• 03:45pm - 05:00pm ET

  Advancing the Value of Stereotactic Body Radiation Therapy (SBRT) in Unresectable and RAI Refractory Thyroid Cancer: A Locoregional Treatment

  Speaker: Joseph Morrison, MD - Univ of CO, Aurora
• 03:45pm - 05:00pm ET

  A VR/AR-Based Intelligent Patient Education System for the Entire Radiotherapy Process

  Speaker: Penghao Gao, - Shandong Cancer Hospital & Institute, Jinan
• 03:45pm - 05:00pm ET

  Doubly Robust Causal Estimation of Proton Therapy vs. IMRT/3DCRT on 90-Day Unplanned Hospitalization-Free Time In La-NSCLC

  Speaker: Yong Fan, PhD - University of Pennsylvania, Philadelphia
• 03:45pm - 05:00pm ET

  Development and Validation of a Machine Learning-Based Survival Prediction Model for Patients with EGFR/ALK/ROS1-Positive NSCLC and Brain Metastases Following Initial Intracranial Radiotherapy

  Speaker: Erha Munai, - School of Medicine, Chongqing University, Chongqing, China, Chongqing
• 03:45pm - 05:00pm ET

  Workflow-Integrated Simulation CT Body Composition for Prognostic Stratification in Elderly Lung Cancer

  Speaker: Saerom Sung, - Yonsei University, Wonju
• 03:45pm - 05:00pm ET

  Tislelizumab Combined with Chemotherapy Followed by Consolidative Thoracic Radiotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: A Prospective, Single-Arm, Phase II Study

  Speaker: Wei Zhou, MD - Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing, China., Chongqing
• 03:45pm - 05:00pm ET

  Targeting MARCHF5 Sensitizes Non-Small Cell Lung Cancer to Radiotherapy by Activating cGAS-STING Pathway via VDAC1 Stabilization

  Speaker: Zhiwei Liu, MD - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
• 03:45pm - 05:00pm ET

  Extrathoracic Disease Volume as a Risk Factor for Cytokine Release Syndrome in Patients with Small Cell Lung Cancer Treated with Tarlatamab

  Speaker: Brandon Perez, MD - University of Chicago Medicine, Chicago
• 03:45pm - 05:00pm ET

  Prognostic Analysis of Radiotherapy Timing in Driver Gene-Negative Advanced NSCLC with Different Metastatic Patterns

  Speaker: Yuqi Wang, MD, RT - Shandong Cancer Hospital and Institute, Jinan
• 03:45pm - 05:00pm ET

  Role of Thoracic MRI-Sim to Differentiate Lung Tumors from Atelectasis and Pleural Effusion

  Speaker: Sarit Appel, MD - Sheba Medical Center, Ramat Gan
• 03:45pm - 05:00pm ET

  Effects and Mechanisms of Radiation Combined with Immunological Pneumonitis on Lung Cancer Progression

  Speaker: Wei Jiang, MD - National Cancer Center/National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen
• 03:45pm - 05:00pm ET

  Clinical Outcome of Stereotactic Body Radiotherapy In Patients with Early-Stage Lung Cancer with Ground-Glass Components: Multi-Center Experience

  Speaker: Dan Yang, MD - Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, P.R. China, Beijing
• 03:45pm - 05:00pm ET

  Proton vs. Photon Radiotherapy Combined with EGFR-TKI in EGFR-Mutant Non-Small Cell Lung Cancer: A Real-World Comparative Effectiveness Study

  Speaker: Yiyue Xu, PhD - Shandong Tumor Hospital, jinan
• 03:45pm - 05:00pm ET

  International Practice Patterns in the Management of Limited Stage Small Cell Lung Cancer

  Speaker: Neelabh Rastogi, MD - University of Toronto, Toronto
• 03:45pm - 05:00pm ET

  Early Mortality after Thoracic Radiotherapy for Lung Cancer: Identifying a High-Risk Subgroup through Initial Radiation Pneumonitis Severity

  Speaker: Hongyu Lu, - Department of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Cancer Hospital, Chongqing
• 03:45pm - 05:00pm ET

  Escalating Cumulative Dose Improves Survival in Thoracic Re-Irradiation without Increased Severe Pneumonitis: Results from Twelve Years of Experience

  Speaker: Serap Akyurek, MD - Ankara University, Ankara
• 03:45pm - 05:00pm ET

  Peritumoral Vascular Morphology Associates with T Stage and Predicts Immunotherapy Response in Stage IV NSCLC

  Speaker: Xin Yang, MS - Chongqing University Cancer Hospital, Shapingba
• 03:45pm - 05:00pm ET

  High-Fidelity 3D PET Synthesis from CT Using a Mamba-Based Multi-Scale Network: Multi-Center Validation in Lung Cancer

  Speaker: Xue Li, - School of Radiology,Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan
• 03:45pm - 05:00pm ET

  A Nationwide Cohort Study using a Target Trial Framework of Post-Operative Radiotherapy for Stage III Non-Small Cell Lung Cancer: Is There Another Way to Go?

  Speaker: Chun Wei Tseng, - Kaohsiung Veterans General Hospital, Kaohsiung City
• 03:45pm - 05:00pm ET

  SFRT with iOAR Sparing Combined with Concurrent Chemoradiotherapy for Unresectable Stage III NSCLC: A Randomized Phase II/III Trial

  Speaker: Weisi Yan, MD, PhD - Baptist Health System, Kentucky
• 03:45pm - 05:00pm ET

  Prognostic Impact of Endobronchial Involvement in Ultracentral NSCLC Treated with Stereotactic Ablative Radiotherapy

  Speaker: Marie Fort, MD - Duke University Hospital, Durham
• 03:45pm - 05:00pm ET

  Impact of Radioresistance and Radiosensitivity Gene Alterations on Locoregional Control after Proton Radiotherapy for NSCLC

  Speaker: Drew Bergman, MD - Memorial Sloan Kettering Cancer Center, New York
• 03:45pm - 05:00pm ET

  AI-Derived Thymic Health, Thymic Dose, and Toxicity Outcomes Among Older Adults with Lung Cancer Undergoing Chemoradiation

  Speaker: Leah Thompson, MD - Harvard Radiation Oncology Program, Boston
• 03:45pm - 05:00pm ET

  Patterns of Failure and Outcomes of Oligoprogression in ALK-Rearranged NSCLC Treated with ALK TKIs

  Speaker: Helen Zhang, MD - Memorial Sloan Kettering Cancer Center, New York
• 03:45pm - 05:00pm ET

  Dosimetric Assessment of iGTV-Guided Adaptive IMRT In Unresectable NSCLC

  Speaker: Souvik Sankar Das, MD, MBBS - Chittaranjan National Cancer Institute, Kolkata
• 03:45pm - 05:00pm ET

  Safety and Efficacy of Lung SBRT in Locally Recurrent/Metastatic Carcinomas Alone or in Combination with Concurrent Systemic Therapy

  Speaker: Ashwin Ganesh, MD - University of Southern California (USC) /LA General Medical Center, Los Angeles
• 03:45pm - 05:00pm ET

  Response Guided Adaptive Treatment for Locally Advanced NSCLC

  Speaker: Ying Xu, - West China Hospital, Sichuan University, Chengdu
• 03:45pm - 05:00pm ET

  Minimizing Radiation Pneumonitis in Locoregionally Advanced NSCLC Receiving Consolidative Hypofractionated Thoracic Radiotherapy Following Chemoimmunotherapy

  Speaker: Selenge Beduk Esen, MD - Hacettepe University Medical School, Department of Radiation Oncology, Ankara
• 03:45pm - 05:00pm ET

  A Phase II Study of Single Fraction Induction Spatially Fractionated Radiation Therapy SFRT Prior Neoadjuvant Chemotherapy/Immunotherapy for Patients with Resectable Non-Small Cell Lung Cancer

  Speaker: Peter Whatts, MD - Karmanos Detroit Medical Center, Detroit
• 03:45pm - 05:00pm ET

  Time to Change of Systemic Therapy Following Local Consolidative Therapy in Oligoprogressive Non-Small Cell Lung Cancer

  Speaker: Yuhao Shi, MD, PhD - NYU Langone Health- Radiation Oncology, New York
• 03:45pm - 05:00pm ET

  Safety and Efficacy of Proton Beam Therapy vs. IMRT for Postoperative Radiotherapy in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

  Speaker: Kayeong Shin, MD - MD Anderson Cancer Center, Houston
• 03:45pm - 05:00pm ET

  Radiation-Elicited Structural and Post-Treatment Observations Necessitating Sophisticated Evaluation after RadioTherapy (RESPONSE-RT) in Stage III NSCLC Treated with Chemoradiotherapy and Consolidation Immunotherapy

  Speaker: Clifford Robinson, MD, FASTRO - Washington University in St. Louis, St. Louis
• 03:45pm - 05:00pm ET

  Protocol-Agnostic Machine Learning for Thoracic Radiotherapy Planning: Clinical Results and Workflow Benefits

  Speaker: Jaykumar Patel, PhD - Johns Hopkins Medicine, Baltimore
• 03:45pm - 05:00pm ET

  Efficacy and Safety of Various Regimens in Small Cell Lung Cancer Patients Who Progressed from Limited Stage to Extensive Stage

  Speaker: Minghao Yu, - Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences Department of Radiation Oncology, Jinan
• 03:45pm - 05:00pm ET

  Dissemination Phenotypes after First-Line Immunotherapy in Metastatic NSCLC: Implications for Metastasis-Directed Therapy

  Speaker: Abed Rahman Kawakibi, MD - Department of Radiation and Cellular Oncology, University of Chicago, Chicago
• 03:45pm - 05:00pm ET

  Retrospective Evaluation of Cardiac Functional Effects of Incidental Low-Dose Radiation from Lung SBRT

  Speaker: Peter Wilson, MD - University of Minnesota, Minneapolis
• 03:45pm - 05:00pm ET

  SABR to Scar: Clinical Predictors and Radiomic Signatures of Post-SABR Lung Fibrosis

  Speaker: Nicholas Peterson, MD - UCI Health Chao Family Comprehensive Cancer Center, Orange
• 03:45pm - 05:00pm ET

  Hypofractionated Radiation and Overall Survival in Patients with Locally Advanced NSCLC - Findings from the National Cancer Database

  Speaker: Weili Wang, MD, PhD - Case Western Reserve University Radiation Oncology, Cleveland
• 03:45pm - 05:00pm ET

  AI-Derived Thymic Health and Locoregional Recurrence Among Patients with Unresectable Non-Small Cell Lung Cancer Undergoing Definitive Chemoradiation

  Speaker: Leah Thompson, MD - Harvard Radiation Oncology Program, Boston
• 03:45pm - 05:00pm ET

  Failure Patterns by Histology after Reirradiation of Recurrent Primary Lung Cancer

  Speaker: Victoria Doss, MD - Johns Hopkins Medicine, Baltimore
• 03:45pm - 05:00pm ET

  A Large-Language Model (LLM-based) Agent for Automatic Grading of Cancer Treatment-Related Toxicities from Multi-Encounter Clinical Notes

  Speaker: Taman Upadhaya, PhD - Cedars-Sinai Medical Center, Los Angeles
• 03:45pm - 05:00pm ET

  Baseline FDG-PET SUVmax Predicts MRI-Based Non-Visible Lesion at 6 Months After Lung SBRT: A Prospective Pilot Study

  Speaker: Osamu Tanaka, MD, PhD - Asahi Univeristy Hospital, Gifu city
• 03:45pm - 05:00pm ET

  Descriptive and Machine Learning Analysis of Cardiovascular Adverse Events after Definitive Chemoradiation for Lung Cancer In an Appalachian Population: A Retrospective Study

  Speaker: Joseph Schmidlen, BS - West Virginia University School of Medicine, Morgantown
• 03:45pm - 05:00pm ET

  Pulsed Targeted Consolidative Radiotherapy for Patients with Polymetastatic NSCLC

  Speaker: Jennifer Livschitz, MD, MS - MD Anderson Cancer Center, Houston
• 03:45pm - 05:00pm ET

  Repeat Lung Stereotactic Radiation for Non-Small Cell Lung Cancer: A Single-Institution Retrospective Study

  Speaker: Daniel Schep, MD, MS - Juravinski Cancer Centre, Hamilton
• 03:45pm - 05:00pm ET

  COVID-19 Vaccination Timing Prior to Immune Checkpoint Inhibitor Initiation and Survival Outcomes In Non-Small Cell Lung Cancer

  Speaker: Kylie Morgan, BS - UCSD Health, La Jolla
• 03:45pm - 05:00pm ET

  Induction Immunotherapy (+/- Chemotherapy) in Inoperable Stage III Non-Small Cell Lung Cancer (NSCLC)

  Speaker: Lamees El Nihum, MD, MEng - Fox Chase Cancer Center, Philadelphia
• 03:45pm - 05:00pm ET

  Contralateral Hilar Lymph Node Involvement in Stage III Non-Small Cell Lung Cancer: Safety and Efficacy of Definitive Chemoradiotherapy with Volumetric Modulated Arc Therapy

  Speaker: Nobuki Imano, MD, PhD - Hiroshima University, Hiroshima
• 03:45pm - 05:00pm ET

  Linear Energy Transfer-Guided Optimization Enhances High-LETd Coverage in Carbon-Ion Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer

  Speaker: Kailiang Wu, MD, PhD - Fudan University Shanghai Cancer Center, Shanghai
• 03:45pm - 05:00pm ET

  Feasibility of an AI-Driven Auto-Contouring and Auto-Planning Workflow for Lung Cancer Radiotherapy with Radiation Oncologist Quality Assurance

  Speaker: Chloe Choi, PhD, MS - Memorial Sloan Kettering Cancer Center, New York
• 03:45pm - 05:00pm ET

  Underutilization Despite Availability: Real-World Radiotherapy Patterns in Lung Cancer in Sub-Saharan Africa

  Speaker: Oluwafunmilayo Fagbemide, - Lagos University Teaching Hospital LUTH Idi-Araba, Lagos
• 03:45pm - 05:00pm ET

  Phase II Trial of Biology Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) in Oligoprogressive Non-Small Cell Lung Cancer: Interim Report

  Speaker: Arya Amini, MD - City of Hope National Medical Center, Duarte
• 03:45pm - 05:00pm ET

  Exploratory Outcomes from a Phase II ctDNA-Guided Consolidation Trial in KRAS G12C-Mutant Locally Advanced NSCLC

  Speaker: Nikhil Mankuzhy, MD - Memorial Sloan Kettering Cancer Center, Middletown Township
• 03:45pm - 05:00pm ET

  Real-World Outcomes of Metastasis-Directed Stereotactic Radiotherapy in Driver-Mutated Oligometastatic and Oligoprogressive Metastatic Lung Cancer

  Speaker: Alejandro Gonzalez, MD - Centro de Tratamiento e Investigacion Sobre Cancer Luis Carlos Sarmiento Angulo, Bogotá
• 03:45pm - 05:00pm ET

  Association of Primary Tumor <em>NF1</em> Mutations With Pathologic Complete Response After Neoadjuvant Immunotherapy in Stage I-III NSCLC

  Speaker: Victor Lee, MD, BS - Yale New Haven Hospital, Middletown
• 03:45pm - 05:00pm ET

  Impact of Fiducial Tracking on Intrafraction Alignment during Lung SBRT

  Speaker: Krishmita Siwakoti, MD, MBA - University of Alabama at Birmingham, Birmingham
• 03:45pm - 05:00pm ET

  Off-Target Low-Dose Liver Irradiation Reprograms the Hepatic Pre-Metastatic Niche via an IFN-?-Centered Immune Network and Synergizes with Immunotherapy in Lung Cancer

  Speaker: Jingyuan Liu, - The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou
• 03:45pm - 05:00pm ET

  Proton Beam Therapy for Tracheobronchial Adenoid Cystic Carcinoma: Outcomes and Genomic Insights into Recurrence

  Speaker: Hidenari Hirata, MD, PhD - Kitakyushu Municipal Medical Center, Kitakyushu
• 03:45pm - 05:00pm ET

  Transit Blood Dose Modeling Identifies Re-Optimization Opportunities for Immune-Sparing Treatment Planning in Locally Advanced NSCLC

  Speaker: Thomas Oldland, MS - University of Kentucky, Lexington
• 03:45pm - 05:00pm ET

  The Role of Proton Therapy in Enhancing Personalized Accelerated Radiotherapy (PACER) Trial for Lung Cancer: Unlocking the Fast Lane

  Speaker: Serdar Charyyev, PhD - Stanford University, San Jose
• 03:45pm - 05:00pm ET

  Sustained Systemic Therapy plus Brain Radiotherapy Improves Survival in Extensive-Stage Small-Cell Lung Cancer with Brain-Only Progression after First-Line Treatment: A Multicenter Cohort Study <sup data-turn-source-index="6"></sup>

  Speaker: Shuangqing Lu, MD - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences,, Jinan
• 03:45pm - 05:00pm ET

  Safety and Outcomes of Lung SBRT in Severely Pulmonary Impaired Patients with FEV1 or DLCO =25% Predicted

  Speaker: Katherine Amarell, MD, BS - Cleveland Clinic Foundation, Cleveland
• 03:45pm - 05:00pm ET

  Prospective Multicenter Evaluation of Stereotactic Body Radiotherapy (SBRT) for Multiple Primary Lung Cancers Following Surgical Resection: The SMILE Study

  Speaker: Fang Wu, MD - The Second xiangya Hospital of Central South University, Changsha
• 03:45pm - 05:00pm ET

  Stereotactic Body Radiation Therapy is Associated with Accelerated Pulmonary Fibrosis in Patients with Interstitial Lung Disease: A Comprehensive Radiologic Analysis

  Speaker: Seifallah Emam, MS - Duke University, Durham
• 03:45pm - 05:00pm ET

  A Multidimensional Evaluation on Quality of Life in Long-Term Survivors with Cervical Esophageal Cancer after Definitive Chemoradiotherapy

  Speaker: Jun Wang, MD, PhD, RT - Fourth Hospital of Hebei Medical University, Shijiazhuang
• 03:45pm - 05:00pm ET

  Cardiac Substructure Dose and Cardiac Toxicity after SBRT for Central and Ultra-Central Lung Tumors: A Multicenter Retrospective Cohort Study

  Speaker: Axel Licha, MD - Institute Jean Godinot, Reims 51056
• 03:45pm - 05:00pm ET

  Ten-Year Experience with Percutaneous HDR Brachyablation for Primary and Metastatic Lung Tumors

  Speaker: Michelle Ann Eala, MD - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles
• 03:45pm - 05:00pm ET

  Radiotherapy Improved Survival in Extensive-Stage Small-Cell Lung Cancer with Extracranial Oligoprogression after First-Line Therapy: A Multicenter Propensity Score-Matched Cohort Study

  Speaker: Jiatong Li, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong Province
• 03:45pm - 05:00pm ET

  Prognostic Impact of Supraclavicular and Contralateral Hilar Lymph Node Involvement in Limited-Stage Small Cell Lung Cancer: A Multicenter Study

  Speaker: Anhui Shi, MD, PhD - Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing
• 03:45pm - 05:00pm ET

  Relationship between Effective Dose to Immune Cells and Cardiopulmonary Toxicity in Locally Advanced NSCLC

  Speaker: Yiwei Qin, MD - Department of Radiation Oncology, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, People’s Republic of China, Jinan
• 03:45pm - 05:00pm ET

  Re-Irradiation for Local Progression Following First-Line Chemoradiotherapy in Limited-Stage Small Cell Lung Cancer: A Retrospective Study

  Speaker: Xiaoli Liu, - Cheeloo College of Medicine, Shandong University, Jinan
• 03:45pm - 05:00pm ET

  A Pilot Study of Atezolizumab Plus Stereotactic Body Radiotherapy in Metastatic Solid Tumors

  Speaker: Charles Wang, MD, PhD - UC Davis Cancer Center, Davis
• 03:45pm - 05:00pm ET

  Optimal Combination of Immunotherapy-Based Treatment in Unresectable Stage III Non-Small Cell Lung Cancer Treated with Definitive Chemoradiotherapy: A Multicenter, Retrospective Real-World Study

  Speaker: Shuohan Zheng, MD - Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cuangzhou
• 03:45pm - 05:00pm ET

  Secondary Analysis of a Phase II Trial of Primary Lung Tumor SBRT Followed by Concurrent Mediastinal Chemoradiation and Consolidation Immunotherapy for Locally-Advanced Non-Small Cell Lung Cancer: Analysis of Lung Texture Changes after Chemoradiation

  Speaker: Henry Heinzerling, - Atrium Health Levine Cancer, Wake Forest School of Medicine, Charlotte
• 03:45pm - 05:00pm ET

  Development of an Lqrg-TCP Model Incorporating DCE-MRI Derived Ktrans to Predict Heterogeneous Tumor Response In Hypo-Fractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer

  Speaker: Haoting Zhang, PhD - Sun Yat-sen University Cancer Center, Guangzhou
• 03:45pm - 05:00pm ET

  AI-Driven Nutrition Support Demonstrates High Usability and Cultural Relevance Among Radiation Therapy Cancer Survivors: Early Results from the CANEAT-IMPACT Study

  Speaker: Adam Katzenberg, DO, MBA - Thomas Jefferson University, Philadelphia
• 03:45pm - 05:00pm ET

  Survival Benefits of Radiation Dose Escalation in Locally Advanced NSCLC: A Causal Forest Analysis of the National Cancer Database

  Speaker: Igor Shuryak, MD, PhD - Columbia University, New Milford
• 03:45pm - 05:00pm ET

  Temporal Dynamics of Brain Metastatic Lesions from First-Line Third-Generation EGFR-TKI-Treated NSCLC: Implications for Optimal Timing of Cranial Local Therapy

  Speaker: Mengyang Ju, - Fudan University Shanghai Cancer Center, Shanghai
• 03:45pm - 05:00pm ET

  Does the Heart Know When It Needs Sparing? Cardiac Positional Variability as an Implicit Trigger for Adaptive Plan Selection In Lung Radiotherapy

  Speaker: Justine Cunningham, MS - Henry Ford Health/Henry Ford Hospital, Detroit
• 03:45pm - 05:00pm ET

  Definitive Radiotherapy with or without Concurrent Chemotherapy after Long-Course Induction Chemoimmunotherapy In Unresectable Stage III NSCLC

  Speaker: Jiayi Xiao, - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, 100142 Beijing, China, Beijing
• 03:45pm - 05:00pm ET

  Synthetic Contrast-Enhanced CT Generated by Generative Adversarial Networks to Assist Lymph Node Delineation in Lung Cancer Radiotherapy

  Speaker: Xiao Zhong, PhD - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
• 03:45pm - 05:00pm ET

  Evaluation of Cases with Over 10 Years of Follow-up After Stereotactic Body Radiotherapy for Stage I Lung Cancer

  Speaker: Masaki Matsuda, MD - University of Yamanashi Hospital, Chuo City
• 03:45pm - 05:00pm ET

  Association Between SBRT Dose Distribution Profiles and Disease Recurrence in Early-stage NSCLC Patients: Implementation of AI-based Recurrence Prediction Tool

  Speaker: Tarun Podder, PhD - Upstate Medical University, Syracuse
• 03:45pm - 05:00pm ET

  Reassessing the Incidence and Risk Factors of Radiation Pneumonitis in Treatment-Naive EGFR-Mutant NSCLC with Concurrent Third-Generation EGFR-TKI and Thoracic Radiotherapy

  Speaker: Shuyue Zheng, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
• 03:45pm - 05:00pm ET

  Efficacy of Third-Generation EGFR-TKIs Combined with Stereotactic Radiotherapy for Brain Metastases in Non-Small Cell Lung Cancer

  Speaker: Han Sun, MD - Cancer hospital, Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen
• 03:45pm - 05:00pm ET

  AI-Derived Thymic Health, Survival, and Patterns of Failure Among Older Adults Undergoing SBRT for Early-Stage Non-Small Cell Lung Cancer

  Speaker: Leah Thompson, MD - Harvard Radiation Oncology Program, Boston
• 03:45pm - 05:00pm ET

  Standardizing Data-to-Dialogue in Outpatient Radiotherapy: Automated Laboratory Cueing, Role-Based Workflow Coordination, and Digital Patient Education to Improve Patient Safety

  Speaker: Huei Fang Yang, BS, RN - Chung Shan Medical University Hospital, Taichung
• 03:45pm - 05:00pm ET

  Systemic Immune Activation by mRNA Vaccination Synergizes with Immune Checkpoint Inhibition and Radiotherapy: A Single-Institution Analysis

  Speaker: Sage Copling, BS - MD Anderson Cancer Center, Houston
• 03:45pm - 05:00pm ET

  NT5E Glycosylation in CAFs Promotes Radio-Immunotherapy Resistance in NSCLC

  Speaker: Meng Yuan, MD, MS - Shandong First Medical University;, Jinan
• 03:45pm - 05:00pm ET

  KEAP1 and SMARCA4 Mutations are Independently Associated with Bone Metastases in Primary Non-Small Cell Lung Cancer

  Speaker: Beatrice Katsnelson, - Yale School of Medicine, New Haven
• 03:45pm - 05:00pm ET

  Heart Radiation Exposure and All-Cause Mortality in Patients with Lung Cancer

  Speaker: Ivica Ratosa, MD, PhD - Institute of Oncology Ljubljana, Ljubljana
• 03:45pm - 05:00pm ET

  When AI Explains Itself: Regional Recurrence Prediction in Early-Stage NSCLC Patients Using Interpretable DNN Framework

  Speaker: Tarun Podder, PhD - Upstate Medical University, Syracuse
• 03:45pm - 05:00pm ET

  Estimating RT-Attributable Risk of Pulmonary Hospitalization in NSCLC Using Dosimetric and Personalized Clinical Predictors

  Speaker: Josiah Nieto, MD - University of Michigan, Ann Arbor
• 03:45pm - 05:00pm ET

  Whole Slide Image-Based Pathomics Fully Supervised Deep Learning Model Predicts Postoperative Recurrence-Free Survival in Stage IA Non-Small Cell Lung Cancer

  Speaker: Xiaoyan Yin, MBBS - Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan
• 03:45pm - 05:00pm ET

  CDCA3 Stabilizes Ku80 to Enhance NHEJ Repair and Promote Radiotherapy Resistance In Lung Adenocarcinoma

  Speaker: Tangmin Lai, MS - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing
• 03:45pm - 05:00pm ET

  Thymic Composition on CT Associates with Peripheral Immune Phenotype in Lung Cancer

  Speaker: David Miller, MD, MS - Memorial Sloan Kettering Cancer Center, New York
• 03:45pm - 05:00pm ET

  Association Cetween Cardiac Substructure Dose and Survival in NSCLC Patients Treated with Concurrent Chemoradiotherapy

  Speaker: Dipesh Niraula, PhD - H. Lee Moffitt Cancer Center and Research Institute, Tampa
• 03:45pm - 05:00pm ET

  Predictors and Equity of Distribution of Educational Materials to Patients Receiving Radiation Therapy for Thoracic Malignancies

  Speaker: Lauren Linkowski, MD, BS - Hospital of the University of Pennsylvania, Philadelphia
• 03:45pm - 05:00pm ET

  Spatially Fractionated Radiotherapy for Large Thoracic Malignancies: Early Clinical Outcomes

  Speaker: Zhe Ji, MD - Peking University Third Hospital, Beijing
• 03:45pm - 05:00pm ET

  Consolidative Stereotactic Ablative Radiotherapy to the Residual Primary Tumor After First-line Systemic Therapy: Impact on New Distant Metastases in Advanced Non-Small Cell Lung Cancer

  Speaker: Dan Tao, MD - Chongqing University Cancer Hospital, Chongqing
• 03:45pm - 05:00pm ET

  Real-World Prognostic Impact of PD-L1 Status in Unresectable NSCLC Treated with Concurrent Chemoradiation and Consolidative Immunotherapy

  Speaker: Levi Martinka, MD - Moffitt Cancer Center, Tampa
• 03:45pm - 05:00pm ET

  Impact of Changes in the IASLC 9th Edition Lung Cancer Staging System in Patients Treated with Concurrent Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer

  Speaker: Mia Kim, - Albert Einstein College of Medicine, Bronx
• 03:45pm - 05:00pm ET

  Obesity Increases the Risk of Radiation-Induced Interstitial Lung Disease in Lung Cancer Patients: Evidence for a Renin-Mediated Mechanism

  Speaker: Pengwei Li, MD, MS - Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
• 03:45pm - 05:00pm ET

  Time of Day Radiotherapy and Radiation Pneumonitis in Lung Cancer with Interstitial Lung Disease

  Speaker: Haozheng Lu, - Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
• 03:45pm - 05:00pm ET

  Stereotactic Body Radiotherapy Combined with PD-1 Inhibitor in Patients with Advanced Non-Small Cell Lung Cancer: A Phase II Single-Arm Trial

  Speaker: Hong Ge, MD - The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou
• 03:45pm - 05:00pm ET

  AI-Based Contouring and Dosimetric Validation of Cardiac Substructures in Stage II-III NSCLC in a Statewide Consortium

  Speaker: Travis Pflederer, MD - University of Michigan Radiation Oncology, Ann Arbor
• 03:45pm - 05:00pm ET

  Prognostic Value of the Time-of-Day Radiotherapy in Non-Small Cell Lung Cancer Patients Receiving Concurrent Chemotherapy and Radiotherapy Followed by Immunotherapy

  Speaker: Hongxuan Yu, MD, BS - Shandong Cancer Hospital and Institute, Jinan
• 03:45pm - 05:00pm ET

  Statewide Analysis of Clinical and Dosimetric Predictors of Cardiac Hospitalization after Thoracic RT for NSCLC

  Speaker: Batoul Nasser, MD, MS - University of Michigan Hospital, Ann Arbor
• 03:45pm - 05:00pm ET

  Beyond the Beam: Radiation Therapists' Perspectives on Psychosocial and Supportive Care In Saudi Arabia

  Speaker: Zaheeda Mulla, RT - King Faisal Specialist Hospital and Research Centre, Jeddah
• 03:45pm - 05:00pm ET

  Longitudinal Serum Proteomic Profiling of Radio-Immunotherapy Response in Oligometastatic Non-Small Cell Lung Cancer

  Speaker: Yaxue Wang, MD - Sun Yat-sen University Cancer Center, Guangzhou
• 03:45pm - 05:00pm ET

  Quantitative Radiomic and Deep Features to SBRT Toxicity Outcome: Dual-Channel Deep Neural Network-Driven Pneumonitis Prediction Early-Stage NSCLC Patients

  Speaker: Tarun Podder, PhD - Upstate Medical University, Syracuse
• 03:45pm - 05:00pm ET

  High Stress-Responsive T-cell Infiltration is an Independent Prognostic Factor in Resectable NSCLC Treated with Neoadjuvant Immune-Chemotherapy

  Speaker: Yang Liu, RT - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, jinan
• 03:45pm - 05:00pm ET

  Tumor Tissue O-GlcNAc Level as a Dual Biomarker for Radiation-Induced Lung Injury and Radiotherapy Prognosis in NSCLC

  Speaker: Yujiao Ma, MS - Shandong university, Jinan
• 03:45pm - 05:00pm ET

  Efficacy and Safety of Induction Therapy in Patients with Unresectable Stage III Driver Gene-Positive Non-Small Cell Lung Cancer

  Speaker: Yuhan Lin, MD - Department of Radiation Oncology and Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical, Jinan
• 03:45pm - 05:00pm ET

  Interpretable 2.5 D Multi-Channel Deep Learning for Predicting Brain Metastasis after Prophylactic Cranial Irradiation in Small Cell Lung Cancer

  Speaker: Ying Huang, PhD - Shanghai Chest Hospital, Shanghai
• 03:45pm - 05:00pm ET

  Optimal Sequencing of Immunotherapy and Radiotherapy in Driver Gene-Negative NSCLC with Brain Metastases: A Real-World IPTW Analysis

  Speaker: Erha Munai, - School of Medicine, Chongqing University, Chongqing, China, Chongqing
• 03:45pm - 05:00pm ET

  Radiotherapy Planning for Lung Cancer Using Novel Volumetric Modulated Arc Therapy with Static Angle Modulated Ports and Dynamic Collimator Rotation

  Speaker: Taro Ueda, MD - Department of Radiation Oncology, Hiroshima University, Hiroshima
• 03:45pm - 05:00pm ET

  Safety and Dose-Limiting Toxicities of Concurrent Radiotherapy with Tarlatamab in Relapsed/Refractory Small Cell Lung Cancer: A Single Institution Retrospective Analysis

  Speaker: Serageldin Attia, MD - University Hospitals - Seidman Cancer Center, Cleveland
• 03:45pm - 05:00pm ET

  Patterns of Failure in Synchronous Metastatic Non-Small Cell Lung Cancer without Driver Alterations According to Metastatic Burden

  Speaker: Woo Joong Rhee, MD, PhD - Severance Hospital of the Yonsei University Health System, Seoul
• 03:45pm - 05:00pm ET

  OBLITERATE: A Phase II Pragmatic Trial Testing Local Ablative Therapy in Oligoprogressive Thoracic Malignancies

  Speaker: Ijeoma Nwoguh, MD - University of California Davis, Sacramento
• 03:45pm - 05:00pm ET

  Glutamine Synthetase Modulates Radiosensitivity in Non-Small Cell Lung Cancer via a STAT5-Regulated Metabolic-DNA Repair Axis

  Speaker: Liang Du, PhD - Chongqing University Cancer Hospital, Chongqing
• 03:45pm - 05:00pm ET

  Radiotherapy Induces Neuroendocrine Lineage Plasticity and Activates the YAP1-CCND1 Axis to Promote EMT in Small Cell Lung Cancer

  Speaker: Yuanjun Wu, - West China Hospital, Sichuan University, Chengdu
• 03:45pm - 05:00pm ET

  Proton Therapy in Locally Advanced NSCLC: Decreased Side Effects and Mortality Compared to VMAT

  Speaker: Lisanne van Dijk, PhD - University Medical Center Groningen, Groningen 9700 GZ
• 03:45pm - 05:00pm ET

  Local-Regional Control In LA-NSCLC Treated with Concurrent Chemoradiation with and without Consolidative Durvalumab: A Retrospective Analysis Using Both Proton and Photon Therapy

  Speaker: Elizabeth Thompson, MD, BS - University of Florida, Gainesville
• 03:45pm - 05:00pm ET

  Oligoprogression-Directed vs. Consolidative Thoracic Radiotherapy in Stage IV NSCLC: A Single-Institution Retrospective Study

  Speaker: Benson Wan, MD, BS - McGill University, Montreal
• 03:45pm - 05:00pm ET

  Clinical Factors Associated with Rib Fractures Following SBRT for Lung Cancer

  Speaker: Izieduwa Akhionbare, - Queen's University Belfast, Belfast
• 03:45pm - 05:00pm ET

  Association of Prior Thoracic Radiation with Clinical Outcomes in Patients Hospitalized for Heart Failure

  Speaker: Aren Saini, BS - University of Miami Miller School of Medicine, Miami
• 03:45pm - 05:00pm ET

  Impact of Dosimetric Factors on Rib Fracture (RF) and Chest Wall (CW) Pain (CWP) in Ultra-Peripheral Lung Tumors (UPLT) Treated with Stereotactic Body Radiation Therapy (SBRT)

  Speaker: Neil Sathi, - SUNY Upstate Medical University, Syracuse
• 03:45pm - 05:00pm ET

  Impact of Radiotherapy on Lymphocyte Subpopulations and Their Prognostic Value in Lung Cancer Patients

  Speaker: Juan Wang, - Department of Radiation Center, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing
• 03:45pm - 05:00pm ET

  Survival Outcomes in Inoperable Stage III NSCLC: Comparing Immunotherapy (+/- Chemotherapy) followed by Radiotherapy vs. Standard of Care Chemoradiation Followed by Adjuvant Durvalumab

  Speaker: Mary Mahoney, MD - Fox Chase Cancer Center, Philadelphia
• 03:45pm - 05:00pm ET

  Metastasis-Directed Therapy plus Systemic Therapy vs. Systemic Therapy Alone in Oligometastatic NSCLC: A Systematic Review and Meta-Analysis

  Speaker: . Simran, MD, MBBS - All India Institute of Medical Sciences, Raipur, C.G, Raipur
• 03:45pm - 05:00pm ET

  Robust Automated Segmentation of Lung Tumors across Heterogeneous CT Protocols Using Deep Learning

  Speaker: William Green, MD - Rutgers Cancer Institute of New Jersey, New Brunswick
• 03:45pm - 05:00pm ET

  Thymic Health Modifies Vulnerability to Radiation-Associated Coronary Events in Lung Cancer

  Speaker: Katelyn Atkins, MD, PhD - Cedars-Sinai Medical Center, Los Angeles
• 03:45pm - 05:00pm ET

  Clinical Outcomes of Particle Beam Therapy for T3N0M0 Non-Small Cell Lung Cancer: A Japanese National Prospective Registry Study

  Speaker: Nobuteru Kubo, MD, PhD - Gunma University, Maebashi
• 03:45pm - 05:00pm ET

  The Impact of Rib Avoidance in Thoracic Stereotactic Ablative Radiation Therapy on Fracture Incidence

  Speaker: Holly Grace, MD - UT Southwestern Medical Center, Dallas
• 03:45pm - 05:00pm ET

  FDG PET Imaging Biomarker Associations with Survival Outcomes After Radiotherapy for Oligoprogressive NSCLC

  Speaker: Faisal Yaseen, - University of Washington, Seattle
• 03:45pm - 05:00pm ET

  Low-Dose Intestinal Irradiation Enhances the Efficacy and Prognosis of PD-1 Blockade in Metastatic Non-Small Cell Lung Cancer

  Speaker: Baiyang Huang, MS - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China, Jinan
• 03:45pm - 05:00pm ET

  <i>Clostridium Butyricum</i>-Derived Butyrate Enhances Radiotherapy Efficacy in NSCLC via the GPR109A-FOXO1-FAO Metabolic Axis

  Speaker: Shijie Shang, - Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan
• 03:45pm - 05:00pm ET

  Dosimetric Impact of Substructure-Guided Electron Density Modeling In MR-Guided Lung SBRT

  Speaker: Min Liu, PhD - Sichuan Cancer Hospital, Chengdu
• 03:45pm - 05:00pm ET

  Impact of Immunotherapy Timing on Survival after Definitive Chemoradiotherapy in Unresectable Stage III NSCLC: A Systematic Review and Meta-Analysis

  Speaker: . Simran, MD, MBBS - All India Institute of Medical Sciences, Raipur, C.G, Raipur
• 03:45pm - 05:00pm ET

  Beyond Prescription Dose: Target Coverage and Volume Extremes Predict Local Control after Lung SBRT

  Speaker: Alexander Allen, MD - University of Maryland Medical Center, Baltimore
• 03:45pm - 05:00pm ET

  Tumor Volume and Skeletal Muscle Coupling in Stage III NSCLC Treated with Definitive Chemoradiation

  Speaker: Aman Gupta, MD - Rajiv Gandhi Cancer Institute and Reserach Centre, New Delhi
• 03:45pm - 05:00pm ET

  Impact of Thoracic Duct Radiation Dose on Survival and Lymphocytes in Inoperable Non-Small Cell Lung Cancer Patients with Radiotherapy for Primary Tumors

  Speaker: Cheng Hu, MD - THE AFFILIATED HOSPITAL OF GUIZHOU MEDICAL UNIVERSITY, GuiYang
• 03:45pm - 05:00pm ET

  Etoposide-Platinum Rechallenge in Small Cell Lung Cancer Worth More Application: A Multicenter Study and an Online Prediction Tool

  Speaker: Zhonghui Wei, - Shandong University, Jinan Shandong
• 03:45pm - 05:00pm ET

  Tumor-Induced Metabolic Stress and Subclinical Cardiac Injury in Tumor-Bearing Mice and Its Modulation by TEPP-46

  Speaker: Kristian Holgersson, BS - Loma Linda University School of Medicine, Vancouver
• 03:45pm - 05:00pm ET

  Beyond the Oligometastatic Paradigm: Survival Trends with SBRT In High-Burden Extracranial Metastatic NSCLC

  Speaker: Jayavignesh Sekar, MD - Northwell Health Center for Advanced Medicine, North New Hyde Park
• 03:45pm - 05:00pm ET

  Clinical Outcomes of Zero-Margin, Single Isocenter Radiosurgery for Brain Metastases from Small Cell vs. Non-Small Cell Lung Cancer

  Speaker: Nicholas Johnson, BS - University of Alabama at Birmingham, Birmingham
• 03:45pm - 05:00pm ET

  Technical Validation of STRIDE (Systemic Toxicity Risk from Immune Dose Exposure) V1.0: A Cross-Platform Framework for Immune-Relevant Cardiac Dosimetry in Locally Advanced NSCLC

  Speaker: Jovan Pierre-Charles, MD, BS - University of Kentucky, Lexington
• 03:45pm - 05:00pm ET

  PD-L1 Inhibitors Consolidation Following Concurrent Chemoradiotherapy Improves Progression-Free Survival without Increasing Pneumonitis vs. PD-1 Inhibitors In Unresectable Stage III NSCLC

  Speaker: Xiaoli Liu, - Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan